Risk stratification of ThyroSeq results in indeterminate thyroid lesions: A single‐institution experience of clinicopathologic correlation with cytologic findings

ThyroSeq offers the opportunity to stratify the risk of malignancy (ROM) in the characterization of indeterminate thyroid nodules, especially those categorized as atypia of undetermined significance (AUS). However, whether ThyroSeq interpretations correlate with cytologic features, management, and surgical outcome remains unclear.